May 19, 2012
ArQule ready for Phase 3 lung cancer trialMass High TechLtd., have completed enrollment for a Phase 3 trial of ArQule's lead drug candidate to treat patients with locally-advanced or metastatic, non-squamous, non-small cell lung cancer (NLCLC). Recruitment for the randomized, double-blind, controlled Phase …ArQule and Daiichi Sankyo Announce Completion of Patient Recruitment in Phase …MarketWatch [...]
Read the full article →
May 19, 2012
Momentum Continues To Build For Federal Plan Of Action For Lung Cancer …Sacramento BeeBy Lung Cancer Alliance WASHINGTON, May 18, 2012 /PRNewswire-USNewswire/ — As Congress prepares for its Memorial Day District Work Period, Lung Cancer Alliance (LCA) announced that more than a dozen Congressional leaders have signed on as new …and more » View full post [...]
Read the full article →